MedTrace Logo

Nebulized Procaterol Versus Nebule Salbutamol for the Treatment of Moderate Acute Asthma

NCT00990847 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2009-10-07

No results posted yet for this study

Summary

The purpose of this study is to compare the efficacy and safety of nebule procaterol with nebule salbutamol in the treatment of moderate acute asthma.

Conditions

  • Moderate Acute Asthma

Interventions

DRUG

Procaterol, Salbultamol

Sponsors & Collaborators

  • PT Otsuka Indonesia

    lead INDUSTRY

Principal Investigators

  • Hadiarto Mangunnegoro, MD · Department of Pulmonology and Respiratory Medicine, Faculty of Medicine University of Indonesia/ Persahabatan Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-06-30
Primary Completion
2008-04-30
Completion
2008-08-31

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00990847 on ClinicalTrials.gov